Iovance Break through Cancer approval


Largest insider buying or any biotech out there. First ever til therapy approval and has earnings this week May 9th and presents major data at ASCO end of the month. This is a game changer for solid tumor cancers. Excited to see them offer great guidance. Wayne Rothbaum largest position one of the greatest biotech investors ever. Start a position soon imo. There is roughly a 23-24 percent short in the stock.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *